Profile picture

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF
Session
What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF
31 August 2019
Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
Session
Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
26 August 2018
GARFIELD-AF: new light shed on atrial fibrillation and its management
Session
GARFIELD-AF: new light shed on atrial fibrillation and its management
25 August 2018
Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry
Session
Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry
26 August 2017
Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry
Session
Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry
27 August 2016
Anticoagulation and Atrial Fibrillation (AF): real life data from the GARFIELD-AF Registry
Session
Anticoagulation and Atrial Fibrillation (AF): real life data from the GARFIELD-AF Registry
29 August 2015
From acute PE to CTEPH: related diseases, different solutions
Session
From acute PE to CTEPH: related diseases, different solutions
31 August 2014
Anticoagulation and atrial fibrillation: emerging insights
Session
Anticoagulation and atrial fibrillation: emerging insights
30 August 2014
Stroke prevention in atrial fibrillation 2013: registry insights and perspectives
Session
Stroke prevention in atrial fibrillation 2013: registry insights and perspectives
31 August 2013

ESC 365 is supported by